Xeomin 100 Units is a highly purified botulinum toxin type A, developed for therapeutic and aesthetic treatments. Unlike traditional botulinum toxin products, Xeomin is free from unnecessary complexing proteins, reducing the risk of antibody resistance and enhancing treatment efficacy.
Key Features:
- Purity: Xeomin contains only the active neurotoxin, providing precise and effective results.
- Efficacy: Clinically proven for therapeutic and cosmetic applications, with consistent outcomes.
- Stability: Xeomin is stable at room temperature, making it easy to store and handle.
Benefits:
- Therapeutic Uses:
- Upper Limb Spasticity: Reduces muscle stiffness, improving mobility and quality of life.
- Cervical Dystonia: Alleviates neck pain and abnormal head positioning.
- Blepharospasm: Treats involuntary eyelid twitching, enhancing visual comfort.
- Chronic Sialorrhea: Decreases excessive salivation, improving social interactions and hygiene.
- Cosmetic Uses:
- Glabellar Lines: Smooths moderate to severe frown lines between the eyebrows, creating a more youthful look.
Usage Instructions:
Xeomin should be administered by qualified healthcare professionals experienced with botulinum toxin products. It is designed for intramuscular or intraglandular injection.
Dosage Recommendations for Xeomin:
- Chronic Sialorrhea:
- Inject Xeomin into the parotid and submandibular glands bilaterally (four injection sites).
- Total recommended dose: 100 Units, divided 3:2 between the glands.
- Repeat treatments every 16 weeks or as clinically necessary.
- Upper Limb Spasticity:
- Dosage depends on muscle size, location, and severity of spasticity.
- Maximum total dose: 400 Units per session, with a minimum of 12 weeks between treatments.
- Cervical Dystonia:
- Initial dose: 120 Units of Xeomin, adjusted based on patient response.
- Administered into affected neck muscles, with at least 12 weeks between treatments.
- Blepharospasm:
- Starting dose: 1.25–2.5 Units per injection site for first-time patients.
- Injected into the orbicularis oculi muscle, with a minimum interval of 12 weeks.
- Glabellar Lines:
- Total dose: 20 Units, divided into five injections (4 Units each) into the corrugator and procerus muscles.
- Repeat treatments every 3 months as needed.
Safety Considerations for Xeomin:
- Contraindications:
- Avoid use in patients with hypersensitivity to botulinum toxin or an active infection at the injection site.
- Warnings:
- Monitor for potential spread of toxin effects causing muscle weakness or respiratory issues.
- Use with caution in patients with neuromuscular disorders.
- Common Side Effects:
- Localized pain, headache, or temporary muscle weakness.
- Rare but serious side effects include difficulty swallowing or breathing.
Storage and Handling of Xeomin:
- Store unopened vials in a refrigerator at 2°C to 8°C.
- Reconstituted solution must be used within 24 hours and stored under refrigeration.
- Avoid freezing the reconstituted solution.
